Bayer shares tumble over Monsanto cancer trial
Bayer shares plunged more than 10 per cent on Monday after a California jury ordered the German company’s newly acquired Monsanto subsidiary to pay $289m for not warning of cancer risks posed by its main weed killer. The case against Monsanto, bought by Bayer this year for $63bn, is the first of more than 5,000 similar lawsuits over […]
Читать дальше...